Glenmede Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Buy
731
+56
+8% +$19.1K ﹤0.01% 1235
2025
Q4
$268K Buy
+675
New +$299K ﹤0.01% 1186
2023
Q3
Sell
-2,037
Closed -$408K 1260
2023
Q2
$408K Hold
2,037
﹤0.01% 891
2023
Q1
$408K Buy
2,037
+2
+0.1% +$420 ﹤0.01% 896
2022
Q4
$484K Sell
2,035
-16
-0.8% -$3.41K ﹤0.01% 842
2022
Q3
$410K Buy
2,051
+7
+0.3% +$1.33K ﹤0.01% 861
2022
Q2
$298K Buy
+2,044
New +$290K ﹤0.01% 1006
2020
Q4
Sell
-190
Closed -$27K 1233
2020
Q3
$27K Buy
190
+7
+4% +$995 ﹤0.01% 1491
2020
Q2
$27K Sell
183
-2
-1% -$270 ﹤0.01% 1482
2020
Q1
$21K Hold
185
﹤0.01% 2068
2019
Q4
$21K Hold
185
﹤0.01% 2068
2019
Q3
$14 Hold
185
﹤0.01% 2205
2019
Q2
$13 Hold
185
﹤0.01% 2250
2019
Q1
$17 Hold
185
﹤0.01% 2134
2018
Q4
$13 Buy
+185
New +$14.2K ﹤0.01% 2158
2018
Q3
Sell
-175
Closed -$17K 1442
2018
Q2
$17K Hold
175
﹤0.01% 1755
2018
Q1
$22K Hold
175
﹤0.01% 1918
2017
Q4
$22K Hold
175
﹤0.01% 1918
2017
Q3
$20K Hold
175
﹤0.01% 1959
2017
Q2
$8K Hold
175
﹤0.01% 2169
2017
Q1
$8K Hold
175
﹤0.01% 2169
2016
Q4
$6K Sell
175
-175
-50% -$7.33K ﹤0.01% 2193
2016
Q3
$23K Sell
350
-150
-30% -$10.6K ﹤0.01% 1889
2016
Q2
$27K Hold
500
﹤0.01% 1785
2016
Q1
$31K Hold
500
﹤0.01% 1672
2015
Q4
$47K Hold
500
﹤0.01% 1584
2015
Q3
$40K Buy
+500
New +$55.6K ﹤0.01% 1659
2015
Q2
Sell
-1,400
Closed -$146K 2676
2015
Q1
$146K Hold
1,400
﹤0.01% 1354
2014
Q4
$135K Sell
1,400
-600
-30% -$55.6K ﹤0.01% 1434
2014
Q3
$156K Sell
2,000
-400
-17% -$25.8K ﹤0.01% 1265
2014
Q2
$151K Hold
2,400
﹤0.01% 1267
2014
Q1
$161K Sell
2,400
-300
-11% -$23.2K ﹤0.01% 1247
2013
Q4
$173K Sell
2,700
-300
-10% -$17.9K ﹤0.01% 1199
2013
Q3
$192K Sell
3,000
-350
-10% -$17.4K ﹤0.01% 1145
2013
Q2
$103K Buy
+3,350
New +$89.1K ﹤0.01% 1303

Other funds holding ALNY